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Abstract
Background: Bartonella tamiae, a newly described bacterial species, was isolated from the blood of three
hospitalized patients in Thailand. These patients presented with headache, myalgia, anemia, and mild liver function
abnormalities. Since B. tamiae was presumed to be the cause of their illness, these isolates were inoculated into
immunocompetent mice to determine their relative pathogenicity in inducing manifestations of disease and
pathology similar to that observed in humans.
Methods: Three groups of four Swiss Webster female mice aged 15-18 months were each inoculated with 10
6-7
colony forming units of one of three B. tamiae isolates [Th239, Th307, and Th339]. A mouse from each
experimental group was sampled at 3, 4, 5 and 6 weeks post-inoculation. Two saline inoculated age-matched
controls were included in the study. Samples collected at necropsy were evaluated for the presence of B. tamiae
DNA, and tissues were formalin-fixed, stained with hematoxylin and eosin, and examined for histopathology.
Results: Following inoculation with B. tamiae, mice developed ulcerative skin lesions and subcutaneous masses on
the lateral thorax, as well as axillary and inguinal lymphadenopathy. B. tamiae DNA was found in subcutaneous
masses, lymph node, and liver of inoculated mice. Histopathological changes were observed in tissues of
inoculated mice, and severity of lesions correlated with the isolate inoculated, with the most severe pathology
induced by B. tamiae Th239. Mice inoculated with Th239 and Th339 demonstrated myocarditis, lymphadenitis with
associated vascular necrosis, and granulomatous hepatitis and nephritis with associated hepatocellular and renal
necrosis. Mice inoculated with Th307 developed a deep dermatitis and granulomas within the kidneys.
Conclusions: The three isolates of B. tamiae evaluated in this study induce disease in immunocompetent Swiss
Webster mice up to 6 weeks after inoculation. The human patients from whom these isolates were obtained had
clinical presentations consistent with the multi-organ pathology observed in mice in this study. This mouse model
for B. tamiae induced disease not only strengthens the causal link between this pathogen and clinical illness in
humans, but provides a model to further study the pathological processes induced by these bacteria.
Background
Bartonella bacteria are small, fastidious, aerobic, Gram
negative coccobacilli in the family Bartonellaceae,c l a s s
Alphaproteobacteria. As of 2009 there are 24 named or
proposed species in the genus [1], and over the last dec-
ade Bartonella bacteria have repeatedly emerged as a
cause of human illness globally [2-6]. Infections with
these bacteria are generally acquired from zoonotic
sources such as host reservoir animals, or from hemato-
phagous arthropods [1]. Either immunocompetent or
immunocompromised people may become ill due to
infections from Bartonella bacteria [7]. The two Barto-
nella species most commonly recognized as causing
human illness are Bartonella henselae,t h ea g e n to f‘cat
scratch disease’,a n dB. quintana, which caused numer-
ous cases of trench fever in soldiers during World War
I, and which today more typically infects homeless peo-
ple, resulting in endocarditis or bacillary angiomatosis
[8,9]. In South America, the lesser known though more
virulent Bartonella bacilliformis causes Oroya fever and
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develop a severe, life-threatening hemolytic anemia [8].
Along with increasing awareness of Bartonella bacteria
as emerging pathogens has come an increased interest in
determining the mechanisms of pathogenesis of these
microorganisms [10]. One of the primary impediments to
our understanding of the infection and disease process
elicited by these bacteria is the inability of researchers to
establish suitable animal models for study [11]. Attempts
to infect both immunocompetent and immunocompro-
mised laboratory mice with various species of Bartonella
bacteria have met with limited success [12-15]. Barto-
nella bacteria in these models tend to be quickly cleared
by the immune system, and though the kinetics of anti-
body response and aspects of cellular and humoral
immunity have been determined [16-18], animal models
that reproduce clinical manifestations of disease observed
in humans remain elusive. The natural reservoirs for B.
henselae and B. vinsonii subsp. berkhoffii are cats and
dogs (canines), respectively, and these animals can serve
as models for Bartonella bacteria infection and disease
processes [19-21]. However, though it may be more bio-
l o g i c a l l ya p p r o p r i a t ea tt i m e st ou s en a t u r a lh o s t st o
study Bartonella bacteria induced pathogenesis, develop-
ing a mouse model for disease is desirable due to the
widespread availability of murine immunological reagents
and selective mutant strains of mice.
A recent success in developing an animal model for
Bartonella induced disease was the inoculation of the
human pathogen B. henselae into C57BL/6 and BALB/c
mice, which produced lymphadenopathy of some dura-
tion [22]. These mice did not develop granulomas
within the popliteal lymph node, and lymphadenopathy
persisted in the near absence of detectable, viable bac-
teria, both in the lymph node and systemically [22],
characteristics which also occur in human ‘cat scratch
disease’, and which were reproduced in this mouse
model of bartonellosis.
The present study was undertaken to establish the
parameters for experimental inoculation of immunocom-
petent Swiss Webster mice, aged 15-18 months, with the
suspected human pathogen B.tamiae [23]. Subcutaneous
inoculation of three B. tamiae isolates into mice elicited
a variety of severe histopathological changes and immune
responses up to 6 weeks after inoculation. Our observa-
tions establish a murine model for B.tamiae induced dis-
ease and serve to implicate B. tamiae as a causative agent
of human illness in Thailand.
Methods
Inoculation of mice
Specific pathogen free, outbred Swiss Webster female
mice, aged 15-18 months, were used for this study.
Mice were obtained from a colony of Swiss Webster
mice maintained at the Centers for Disease Control and
Prevention, Division of Vector-Borne Diseases (CDC/
DVBD), Fort Collins, Colorado, USA, an Association for
Assessment and Accreditation of Laboratory Animal
Care (AAALAC) accredited facility. Work with the mice
was approved by, and conducted under the supervision
of the DVBD Institutional Animal Care and Use Com-
mittee [protocol # 07-012], in compliance with the
guidelines set forth by the Animal Welfare Act (1966) of
the United States of America, with regulatory oversight
by the United States Public Health Service.
Bacteria for the mouse inoculations were grown on
heart infusion agar plates supplemented with 10% rabbit
blood [23], in a 5% CO2 incubator at 35°C. Bacterial colo-
nies were harvested into phosphate buffered saline 5 days
after plating, and stock suspensions were frozen at -80°C
until thawed for inoculation. Aliquots of the frozen stock
for each isolate were titrated to verify the inoculated
dose. The in vitro bacterial passage history for each of
the three B. tamiae isolates is detailed in Table 1[23,24],
and does not include the preparation of the stocks
described above.
All experimental mice were inoculated subcutaneously
along the midline of the scruff of the neck with between
10
6 and 10
7 colony forming units of one of three
B. tamiae isolates (Th239, Th307, or Th339) [23]. Three
groups of four mice were chosen from the available pool
of age matched female mice. Each group was randomly
assigned to be inoculated with one of the three available
B. tamiae isolates, such that four mice were inoculated
for each of the three isolates [n = 12 experimental
mice]. Two age-matched female mice were subcuta-
neously inoculated with saline to serve as controls.
Experimental mice were group housed by isolate for the
Table 1 The Bartonella tamiae isolates used in the study have different in vitro bacterial passage histories
B. tamiae isolate Primary isolation from human blood samples, described
previously in [23]
Subsequent passage history (n = number of passages)
Th239 Blood clot from Thai patient inoculated onto Vero E6 cells HIA supplemented with 5% rabbit blood, n = 6
Th307 Blood clot from Thai patient inoculated into BAPGM [24] HIA supplemented with 5% rabbit blood, n = 2
Th339 Blood clot from Thai patient inoculated onto Vero E6 cells BAPGM, n = 1; HIA supplemented with 5% rabbit blood, n = 2
HIA = Heart infusion agar plates
BAPGM = Bartonella/alpha-Proteobacteria growth medium [24]
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rately from experimental mice. One mouse per isolate
group was sacrificed at 3, 4, 5, and 6 weeks post-inocu-
lation (n = 1 mouse per timepoint for each isolate). All
of the following tissues were sampled from each mouse,
to include both experimental and control mice: blood,
spleen, liver, lymph node(s), and kidney. Lymph nodes
collected included axillary, brachial, inguinal, popliteal,
and cervical nodes, generally in pairs. Lymph nodes
were pooled for testing by PCR. Hearts were collected
from mice during weeks 4 and 5 post-inoculation (n = 6
hearts total; 4 experimental and 2 control mice). Control
mice were sacrificed at 4 and 5 weeks post-inoculation.
Gross observations
Mice were examined by visual inspection and palpation
in the weeks following inoculation. Development of
ulcerations and formation of subcutaneous masses was
noted, as were the location and number of skin lesions.
Enlargement of axillary and inguinal lymph nodes was
monitored by palpation, with reference to healthy, saline
inoculated control mice.
Polymerase chain reaction (PCR) detection of Bartonella
DNA in tissues
Genomic DNA was extracted from tissues and blood
sampled from Swiss Webster mice sacrificed at 3, 4, 5,
and 6 weeks after inoculation with three B.tamiae iso-
lates, and from saline inoculated control mice. A 200 ul
sample of blood and 10-30 mg each of various tissues
(lymph nodes, liver, spleen, kidney, and subcutaneous
masses) from each mouse was subjected to DNA extrac-
tion using the manufacturer’s blood or tissue protocol
as outlined in the QIAamp DNA Mini kit handbook
(Qiagen, Valencia, CA). Extracted DNA was stored at
-20° C until tested.
B. tamiae DNA in samples was detected by PCR using
Bartonella specific primers targeting the gltA (citrate
synthase gene) [25], and 16S-23 S rRNA intergenic tran-
scribed spacer (ITS) region [26] (Table 2). Polymerase
chain reaction was performed in 50 μl reaction volumes
containing extracted template DNA, 10 μl of 5× Green
GoTaq reaction buffer, 200 μM of each dNTP, 0.5 μM
of each forward and reverse primer and 1.25 U of Taq
DNA polymerase (Promega, Madison, WI), in an
Eppendorf Mastercycler (Eppendorf, Westbury, NY).
The conditions for the gltA reactions were 2 min at
95°C, 35 cycles at 95°C for 30 s, 50°C for 45 s, 72°C for
30 s, and a 7 min extension at 72°C. The ITS PCR con-
d i t i o n sw e r e2m i na t9 5 ° Cf o l l o w e db y4 0c y c l e so f
95°C for 30 s, 66°C for 1 min, 72°C for 1 min and a
7 min extension at 72°C. PCR products were visualized
on a 1.5% agarose gel, and amplicons matching the tar-
get length were sequenced on a 3130 Genetic Analyzer
(Applied Biosystems, Foster City, CA) to confirm their
identity.
Tissue preparation for histopathological analysis
Tissue samples were fixed in 10% neutral buffered
formalin (Fisher Scientific, Kalamazoo, MI), subjected to
standard processing, and embedded in paraffin. Sections
of 5 μm were then prepared and stained with hematoxy-
lin and eosin for evaluation by light microscopy (Color-
ado Histo-Prep, Fort Collins, Colorado, USA).
Age-matched, saline inoculated control mouse tissues
were treated in similar fashion, and all sections were read
without prior knowledge of the experimental groups.
Results
Inoculation of mice–examinations and gross observations
Within the first week following inoculation, all mice
exhibited thickened, tough skin at the inoculation site in
the scruff of the neck. This resolved in surviving mice
by week 4. The scruff skin of saline inoculated control
mice remained thin and supple throughout the course
of the study.
All mice inoculated with B. tamiae developed subcuta-
n e o u sm a s s e so nt h el a t e r a lt h o r a xf r o m2w e e k sp o s t -
inoculation, and some masses were still present at the
conclusion of the study (6 weeks). Inguinal lymph node
enlargement was detectable by palpation in mice during
this same time period. Between weeks 2 and 3, mice
inoculated with isolates Th307 and Th339 developed
superficial ulcerations above several of the thoracic sub-
cutaneous masses. Mice inoculated with Th239 did not
develop skin ulcerations of subcutaneous masses. The
subcutaneous masses did not appear painful upon palpa-
tion at any time during the course of the study, i.e. mice
did not display aversion to handling or palpation of
masses at any time.
Table 2 Bartonella tamiae DNA in samples was detected by PCR using Bartonella specific primers
Primer name Primer sequence 5’–3’ Amplicon size (bp) Reference
gltA793F CATGGTGGAGCTAATGAAG 344 This article
BhCS1137n AATGCAAAAAGAACAGTAAACA [25]
ITS325F CTTCAGATGATGATCCCAAGCCTTCTGGCG ~300 bp [26]
ITS1100R GAACCGACGACCCCCTGCTTGCAAAGCA
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Sequencing of PCR positive samples confirmed the pre-
sence of B. tamiae DNA in five mouse tissues (Table 3).
B. tamiae DNA was detected 3 weeks post-inoculation
in a subcutaneous mass and the liver of a mouse inocu-
lated with Th339. DNA was also detected in the subcu-
taneous mass and lymph node of another mouse
inoculated with Th339, 5 weeks post-inoculation. One
mouse inoculated with Th307 was also found to have a
B. tamiae DNA positive subcutaneous mass at week 3.
No blood or tissue samples collected from mice
inoculated with Th239 contained detectable B. tamiae
DNA. Samples collected from the two saline inoculated
control mice were not found to contain B. tamiae DNA
by PCR analysis. Nucleotide sequence analysis indicated
that the detected DNA was identical to the inoculated
strains.
Histopathological observations
As summarized in Table 4, differences in pathogenicity
among B. tamiae isolates were noted. Th307 appeared
less pathogenic than Th239 or Th339 when inoculated
into mice, as only a deep dermatitis was seen at week 3,
and a multifocal granulomatous nephritis was noted at
weeks 5 and 6 after inoculation. This contrasts with
Th239 and Th339 where granulomatous lesions were
noted within the heart, kidney, liver and spleen of
inoculated mice (Table 4). Lesions in the dermis
occurred early after inoculation with Th307 and Th339
(3 weeks), while lesions of internal organs induced by all
three isolates were noted at week 4 and persisted
through week 6 post-inoculation (the duration of the
study).
At week 5, in the hearts of mice inoculated with
Th239 and Th339, a diffuse myocarditis was noted.
Inflammation consisted primarily of mononuclear cells
Table 3 Bartonella tamiae DNA was detected in tissues of
inoculated mice by two specific PCR assays
Week post-
inoculation
B. tamiae
isolates
Tissue
sample
gltA ITS
3 Th339
a SQ mass + +
3 Th339
a Liver - +
3 Th307 SQ mass + +
5 Th339
b SQ mass - +
5 Th339
b Lymph node + +
a the same mouse
b the same mouse
SQ = subcutaneous
Table 4 Histopathological observations in aged, immunocompetent mice experimentally inoculated with three
different Bartonella tamiae isolates [NAF = No Abnormal Finding]
Bartonella tamiae isolates
Week post-
inoculation
Th239 Th307 Th339
3 Skin NAF Dermatitis, deep, not oriented Necrotizing dermatitis
Spleen NAF NAF NAF
Liver NAF NAF NAF
4 Skin NAF NAF Necrotizing dermatitis
Spleen NAF NAF NAF
Liver Granulomatous hepatitis w/necrosis NAF Diffuse inflammatory response in sinusoids
Kidney Granulomatous nephritis NAF NAF
5 Spleen NAF Hemosiderosis in the cortex
Liver NAF NAF NAF
Kidney Perivascular granulomatous nephritis Granulomas in the cortex and
medulla
NAF
Lymph
nodes
Pyogranulomatous lymphadenitis NAF NAF
Heart Myocarditis, granulomas right & left atria,
infiltrates
No sample Myocarditis, granulomas right & left atria,
infiltrates
6 Skin No sample Deep dermatitis No sample
Spleen Pyogranulomatous nodules in the red and
white pulp
NAF NAF
Liver Hepatitis, granulomas w/necrosis NAF Perivascular granulomas, hepatocellular necrosis
Kidney NAF Large perivascular granulomas NAF
Lymph
nodes
Lymphadenitis NAF Lymphadenitis, cortical granulomas, necrotizing
vasculitis
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Page 4 of 9(lymphocytes and plasma cells) admixed with neutro-
phils occurring between myocytes (Figure 1-A). As
noted in Figure 1-B, pyknotic nuclei and necrosis of
adjacent myocardial muscle cells was seen (Figure 1-B,
arrow). Also, granulomas were seen within both the
right and left atria, with necrosis of adjacent muscle
cells (Figure 1-C).
In the liver, multifocal pyogranulomatous infiltrates
were noted adjacent to central veins (Figure 2-A) in
association with hepatocellular necrosis (Figure 2-B,
arrow). In the kidneys a perivascular granulomatous
nephritis with associated degeneration and necrosis of
glomeruli was noted in both kidneys (Figure 3-A,
black arrows). These granulomas appeared to be asso-
ciated with degeneration of proximal tubules (Figure
3-A, white arrow), and inflammation in kidneys was
seen primarily within the renal cortex. Lesions within
internal organs appeared to be perivascular, and, as
noted in Figure 3-B, a necrotizing vasculitis occurred
in prominent arteries of the cortex of the lymph
nodes draining associated skin lesions. In the spleen,
a necrotizing splenitis was seen, with a mixed
inflammatory response occurring within both the red
and white pulp (not shown). In the case of a mouse
inoculated with Th339, a diffuse and prominent
hemosiderosis was also seen within the white pulp of
the spleen.
In the skin, caudal and lateral to the B. tamiae inocu-
lation site, a necrotizing, ulcerative dermatitis developed
dorsal to the subcutaneous masses early (3 weeks after
inoculation of the mice with Th339, Table 4). The der-
matitis persisted throughout the six week study period
in some mice. Grossly, the lesions induced by Th339
appeared as ulcerative nodules, while microscopically, a
severe, mixed inflammatory response was noted within
the deeper layers of the dermis and subcutaneous tissues
with associated necrosis of adjacent structures, such as
hair follicles and sebaceous glands. Inflammatory infil-
trates appeared similar to what was noted in the heart,
liver, and kidney lesions, consisting of neutrophils
admixed with mononuclear cells, predominantly plasma
cells and mature lymphocytes. None of the above
described lesions were seen in saline-inoculated control
mice.
Figure 1 Photomicrographs of hematoxylin and eosin stained heart sections of mice sampled during the study. Mononuclear cell
infiltration of the ventricle (A, 10×; B, 40×) and atrium (C, 10×) of a Swiss Webster mouse 5 weeks post-inoculation with B. tamiae Th339. The
white arrow indicates a myocyte with a pyknotic nucleus. (D) Ventricle of a Swiss Webster mouse inoculated with saline (10×).
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Page 5 of 9Figure 2 Photomicrographs of hematoxylin and eosin stained liver sections from mice sampled during the study.G r a n u l o m a t o u sc e l l
infiltration in liver tissue (A, 10×; B, 40×) of a Swiss Webster mouse inoculated with B. tamiae Th239. The black arrow indicates a necrotic
hepatocyte. (C) Section of liver from a Swiss Webster mouse inoculated with saline (20×).
Figure 3 Photomicrographs of hematoxylin and eosin stained kidney and lymph node sections from mice sampled during the study.
Granulomatous cell infiltration in the kidney (A, 10×) of a Swiss Webster mouse inoculated with B. tamiae Th239. Black arrows indicate
degenerative glomeruli; the white arrow indicates a degenerating proximal tubule. (B) Necrotizing vasculitis in an axillary lymph node recovered
from a Swiss Webster mouse 6 weeks after inoculation with B. tamiae Th339 (40×).
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Inoculation of Swiss Webster mice aged 15-18 months
with human isolates of B. tamiae induced disease pro-
cesses consistent with clinical manifestations of disease
observed in human patients [23]. Since mice experience
age-related changes in immune function, which include
alterations in T-cell responsiveness to antigens, this may
have affected the outcome of our study [27,28]. Future
studies will include younger mice to evaluate for age
differences in response to this pathogen.
Two of the evaluated isolates of B. tamiae, Th239 and
Th339, appear more pathogenic than the third, Th307
(Table 4). This corresponds to the presentation of the
human patients from whom these isolates were obtained
[23]. Patients 239 and 339 had rashes, and were febrile
for 6 and 1 day(s) respectively, whereas Patient 307 was
afebrile, and presented with pterygium in both eyes: all
three patients had anemia [23]. In addition, the report
of liver function abnormalities found in the human
patients [23] would be consistent with hepatocellular
disease, also seen in mice in the present study (Table 4,
Figure 2). Immunopathological changes in the liver are
not uncommon following human and cat infection with
B. henselae [29-32], or Bartonella clarridgeiae [31]. B.
tamiae DNA was found in the liver of one mouse
infected with Th339 three weeks after inoculation
(Table 3). Although B.tamiae DNA was detected, the
question remains whether persistent bacteria in tissues
or an inflammatory response directed toward bacterial
antigen(s) was responsible for the perivascular granulo-
mas and hepatocellular necrosis seen at week 6 in our
mice (Table 4). In fact, it remains unclear whether any
of the lesions observed were induced, and persisted or
progressed in the presence or absence of viable bacteria.
It is unknown whether the three human patients
infected with B. tamiae had cardiac disease [23]. No
clinical tests were reported to have been conducted to
evaluate for cardiac function abnormalities [23]. In the
present study, B. tamiae Th239 and Th339 produced
myocarditis in mice, with a diffuse inflammatory
response associated with myocardial cell necrosis within
both ventricles (Figure 1). Moreover, granulomatous
lesions were observed in both atria 5 weeks post-inocu-
lation (Table 4, Figure 1). Myocarditis in humans and
animals has been associated with several Bartonella spe-
cies [31,33-36]. Advances in diagnostic techniques have
implicated B. quintana, B. henselae,a n dB. elizabethae
in the majority of Bartonella-associated human myocar-
ditis cases [37-39], while B. vinsonii subspp. berkhoffii
seems to be the main cause of Bartonella induced myo-
carditis in dogs [33]. Histopathological findings in
experimentally infected cats, and in naturally acquired
human and dog cases of Bartonella myocarditis, are
consistent with our observations in mice [31,33,40].
Shared characteristics of infection of heart tissue among
these cases and our murine model include mixed
inflammatory infiltrates [31,33,40], and myocyte necrosis
[33,40], with random inflammatory foci found through-
out heart tissue (Figure 1).
To our knowledge this is the first report of myocarditis
associated with the inoculation of B. tamiae. Though the
mice in our study had a diffuse myocarditis, and no endo-
carditis was found in hearts sampled during our study
(n = 4; hearts sampled from experimentally inoculated
mice at weeks 4 and 5), it is intriguing to note that a high
rate of culture negative infective endocarditis exists in
Khon Kaen, Thailand [41]. This is the same area where
the patients reside from whom B. tamiae was isolated
[23]. In the human endocarditis cases, the causative agent
(s) is unknown, but the possible involvement of Bartonella
bacteria has not been stringently evaluated [41]. In Thai
patients with infective endocarditis, the mean period of
time from symptoms to diagnosis was 5.7 weeks [41], and
our present study only lasted to 6 weeks, with mouse
hearts sampled at weeks 4 and 5 only. Further evaluation
of our mouse model for B. tamiae induced disease may
reveal more extensive cardiac involvement, especially in
the context of a longer term study. Additional studies are
also needed to determine the immunopathogenesis of
these lesions in this murine model.
Lymphadenitis, and lymphadenitis with vasculitis, was
seen in mice inoculated with B. tamiae Th239 and
Th339, and sacrificed at weeks 5 and 6, and week 6
respectively (Table 4). This finding is consistent with
presentations of Bartonella infections in human patients,
as lymphadenitis is a common manifestation in immu-
nocompetent humans infected with B. henselae [42]. It
has also been observed in humans during infection with
B. quintana [43] and B. alsatica [44], and in dogs [45]
and cats infected with B. henselae [46]. Though lympha-
denitis was observed microscopically, no Bartonella
DNA was detected in those three lymph node samples.
A recently published B. henselae ’cat scratch disease’
mouse model also reported persistent lymphadenopathy
in mice, without detection of bacteria in the lymph
nodes [22]. Conversely, in this study at week 5, B.
tamiae DNA was detected by PCR in the lymph node of
am o u s ei n o c u l a t e dw i t hT h 339 (Table 3), but lympha-
denitis was not observed in those tissues under micro-
scopic examination. It appears that the presence of
Bartonella DNA is not necessarily a predictor of patho-
logical findings in the lymph nodes. Interestingly, of the
four mice in our study inoculated with B. tamiae
Th307, none displayed lymphadenitis, which supports
our conclusion that this isolate differs in pathogenicity
compared to strains Th239 and Th339.
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in Thailand, it is difficult to assess and quantitate human
risk for acquiring infection with this suspected human
pathogen [23]. Although a specific animal reservoir for
the bacteria has not been identified, the epidemiological
profile of the three patients shows some shared exposures
congruent with Bartonella bacterial infections manifest-
ing most often as zoonoses [23]. All three patients had a
history of exposure to rats, and two had noted the
appearance of rats in their homes in the weeks prior to
the onset of their illness [23]. In recent years, a number
of rodent associated Bartonella species have been isolated
from patients exhibiting a wide variety of clinical illnesses
[10]. These cases include B. elizabethae:e n d o c a r d i t i s
[10], B. grahamii: neuroretinitis [10], B. washoensis: myo-
carditis [10] and meningitis [4], and B. vinsonii subspp.
arupensis: bacteremia with fever [10], and endocarditis
[47]. To date, it remains unclear how these infections, as
well as the human infections with B. tamiae [23], were
acquired, whether by direct contact with an animal reser-
voir, or exposure to a hematophagous arthropod.
Recently, B. tamiae DNA was detected by PCR assay in
chigger mites and ticks collected from a variety of
rodents in Thailand [48]. This finding suggests the invol-
vement of chigger mites, ticks, and/or rodents in the
transmission of B. tamiae to humans in Thailand.
Conclusions
In this study we explored the capacity of three B. tamiae
isolates to induce a variety of disease manifestations in
aged immunocompetent mice. Thus far, our observa-
tions are consistent with the classification of B. tamiae
as a human pathogen, since inoculation with the bac-
teria produced necrotizing dermatitis, lymphadenitis,
granulomatous nephritis and hepatitis, and myocarditis
in mice. A variety of disease characteristics observed in
our mouse model correlate with what has been observed
in other animal models and in human bartonellosis
[31,33,40]. This murine model lends itself to the study
of the immunopathogenesis of bartonellosis caused by
B. tamiae, as it reproduces clinical symptomatology
found in human patients in Thailand [23]. In addition,
future studies in mice will evaluate the role age may
play in the manifestation of disease. Finally, though the
natural host and transmission dynamics of B. tamiae are
unknown at this time, several lines of evidence suggest
that rodents and/or ectoparasites can present some risk
to humans for acquiring infection with this bacteria.
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